Shionogi Leadership Team

John Keller

John Keller, Ph.D., President and Chief Executive Officer

Dr. Keller joined Shionogi Inc. in July of 2010, as Executive Vice President, Corporate Development and Strategy, and was appointed as President and Chief Executive Officer, and as a member of the Shionogi Inc, Board of Directors, in April 2011.

Immediately prior to joining Shionogi, Dr. Keller was a Partner in SR One, the venture capital group of GlaxoSmithKline. Previously, Dr. Keller served as Executive Vice President and Chief Business Officer of Incyte Corporation, playing a key role in its transformation into a drug discovery and development company and establishing its first major corporate alliance after that transformation. Before Incyte, Dr. Keller had a 16 year tenure at GlaxoSmithKline and its predecessor, SmithKline Beecham, culminating in the position of Vice President, Worldwide Business Development. In that role, he structured numerous licensing agreements with a broad range of partners worldwide, including the agreements establishing the Shionogi-GSK (now Shionogi-ViiV) Pharmaceuticals joint venture. Earlier positions encompassed R&D strategy, technology licensing, alliance management, public policy, project management, and drug discovery research.

Dr. Keller holds a Ph.D. in microbiology from Rutgers University and a Bachelor degree in biology from Johns Hopkins University.


Tadashi Hara

Tadashi Hara, Executive Vice President and Chief Financial Officer

Mr. Hara joined Shionogi Inc. in July 2010, as Executive Vice President and Chief Financial Officer.

Prior to that, Mr. Hara had finance responsibility for the budget management for Shionogi Group Companies, a role held within the Shionogi General Service Company in Japan. Mr. Hara originally joined Shionogi & Co., Ltd. in April 1995 and since that time has held roles both in Japan and the US. Mr. Hara began his career with Shionogi as a sales representative in Japan. He joined Shionogi USA Inc. in April 2006, as Corporate Secretary and Director of Accounting and Finance, where he was responsible for all aspects of Finance, Accounting and Tax for the company. During his time with Shionogi USA Inc. he also played a key role to liaise between Japan and the US from the standpoint of not only finance and accounting but also administrative functions. Mr. Hara also served Shionogi USA Inc. as a Director of the Board since July 2009. Mr. Hara also had responsibility as Treasurer and Secretary of Ezose Sciences Inc., one of our group companies which is engaged in a high-throughput glycomics technology in NJ.

Mr. Hara holds a B.A. in Literature (Psychology) from Waseda University in Japan.


Gary Dickinson

Gary Dickinson, Executive Vice President, Chief Transformation Officer and Human Resources Officer

Gary Dickinson joined Shionogi Inc. in October 2011 and leads Shionogi’s Human Resources function in the U.S.

Prior to joining Shionogi Inc. Gary had over 25 years of Senior HR experience gained in large corporate companies such as Bristol Myers Squibb and American Express plus valuable experience gained in helping build several successful mid-size Companies such as The Medicines Company and Elementis Specialties. Gary has also had CEO experience at Universal WorldEvents a Pharmaceutical Meeting and Event Planning Company. His international and broad generalist HR management experience in the Consumer and Pharma sides of the Life Sciences industry give him a unique background to have a significant influence at Shionogi, Inc. Mr. Dickinson holds a B.A. Hons. Degree in Sociology from The University of Sheffield in the U.K.


Joseph M. Spagnardi

Joseph M. Spagnardi, Executive Vice President, Legal and Compliance

Mr. Spagnardi joined Shionogi Inc. in June 2013, and is Executive Vice President, Legal and Compliance. In this role, Joe serves as the General Counsel, Chief Compliance Officer, and Corporate Secretary of the Company.

Joe has over 20 years of legal experience in both private practice and senior corporate legal roles. His extensive experience includes corporate transactions, company and product acquisitions, licensing arrangements, intellectual property and exclusivity, compliance and corporate governance. In his previous position, Joe served as the Senior Vice President, General Counsel and Secretary at Inspire Pharmaceuticals, Inc., a publicly traded company. Prior to that, Joe held senior legal positions at GlaxoSmithKline, and its predecessor, Glaxo Wellcome. Joe started his legal career at the law firm of Winthrop, Stimson, Putnam and Roberts, now Pillsbury Winthrop Shaw Pittman.

Joe holds a J.D. with Honors from the University of North Carolina School of Law and a B.S. in Business Administration from the University of Delaware. He has been admitted to the Bar in the State of New York since 1990.